PMID: 9192422May 1, 1997Paper

Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid

Pediatric Dermatology
G Fischer, M Rogers

Abstract

Potent topical corticosteroid is recognized as the treatment of choice for vulvar lichen sclerosus in adults. A series of 11 children with vulvar lichen sclerosus were treated with the potent topical corticosteroid betamethasone dipropionate 0.05%, seven using an optimized vehicle preparation. There was an excellent response to therapy in all cases. No serious adverse effects or unwanted sequelae occurred. Eight of the 11 children experienced complete remission after 3 months of therapy. In these children no maintenance therapy has been necessary during follow-up periods ranging from 3 to 18 months. Three children required maintenance therapy with a mild topical corticosteroid. We conclude that in children, as in adults, potent topical corticosteroid is a safe and effective treatment for vulvar lichen sclerosus.

References

Jul 1, 1992·Clinics in Dermatology·J L Buker, R A Amonette
Jun 1, 1991·Pediatric Dermatology·K F HelmS A Muller
Jan 1, 1991·Clinical and Experimental Dermatology·J Berth-JonesD A Burns
May 30, 1987·British Medical Journal·S E Handfield-JonesC T Kennedy
Jun 1, 1993·Pediatric Dermatology·S KaurA J Kanwar

❮ Previous
Next ❯

Citations

Jan 19, 2013·American Journal of Clinical Dermatology·Susanna K Fistarol, Peter H Itin
Sep 29, 2001·Obstetrics and Gynecology·Y R Smith, E H Quint
May 29, 1999·Lancet·J J Powell, F Wojnarowska
Nov 26, 1999·Journal of the American Academy of Dermatology·O AynaudJ M Casanova
Mar 29, 2000·The British Journal of Dermatology·J PowellK Welsh
Nov 28, 2001·Clinical and Experimental Dermatology·S M Neill, C M Ridley
Mar 18, 2000·Pediatric Dermatology·G Fischer, M Rogers
Nov 16, 2005·Clinical Obstetrics and Gynecology·Isabel Val, Gutemberg Almeida
Jul 3, 2013·Current Opinion in Obstetrics & Gynecology·Melina L Dendrinos, Elisabeth H Quint
Jul 14, 2012·Current Opinion in Pediatrics·Parisa RavanfarNicole C Pace
Oct 4, 2006·Pediatric Dermatology·Susan C KellyAndrea L Zaenglein
Aug 27, 2009·Pediatric Dermatology·Morvarid YousefiDirk Elston
Mar 5, 2010·Pediatric Dermatology·Saxon D Smith, Gayle Fischer
Mar 5, 2010·Pediatric Dermatology·Annalisa PatriziI Neri
Jan 29, 2000·BMJ : British Medical Journal·J Powell, F Wojnarowska
Feb 9, 2005·Annales de dermatologie et de vénéréologie·L Labbé, C Léauté-Labrèze
Sep 3, 2011·Journal of Dermatological Case Reports·Herald Justin SherlinChandrasekar Thiruvenkadam
Mar 11, 2004·Journal of Pediatric and Adolescent Gynecology·Andrew T GoldsteinKurt Christopher
Oct 31, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·J Powell
Mar 15, 2005·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Janet McLelland
Jan 24, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A AyhanT Kucukali
Nov 18, 2009·The Australasian Journal of Dermatology·Saxon D Smith, Gayle Fischer
Dec 6, 2014·Clinical and Experimental Dermatology·G A CaseyJ J Powell
May 6, 2015·Pediatric Dermatology·Lana X TongJoyce M C Teng
Sep 25, 2004·Journal of the American Academy of Dermatology·Joline J TillyNancy B Esterly
Oct 4, 2011·The Journal of Pediatrics·Dangtue NguyenWilliam H Sorey
Jul 24, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·G KirtschigF Wojnarowska
Dec 23, 2017·Journal of Lower Genital Tract Disease·Anastasia ProdromidouVasilios Pergialiotis
Feb 6, 2004·Dermatologic Therapy·Loretta Fiorillo
Feb 6, 2004·Dermatologic Therapy·Deana Funaro
Mar 21, 2002·The Australasian Journal of Dermatology·G O Fischer
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Ching-Chi ChiFenella Wojnarowska
Apr 7, 2005·International Journal of Dermatology·Sultan Al-KhenaizanOsama Kentab
Sep 22, 2010·The British Journal of Dermatology·S M NeillUNKNOWN British Association of Dermatologists
Apr 28, 2004·American Journal of Clinical Dermatology·Yolanda R Smith, Hope K Haefner
Oct 9, 2002·The British Journal of Dermatology·S M NeillUNKNOWN British Association of Dermatologists
Oct 6, 1998·Seminars in Cutaneous Medicine and Surgery·S B Ball, F Wojnarowska
Mar 1, 2017·The British Journal of Dermatology·S MashayekhiF M Lewis
Oct 1, 1999·Journal of Lower Genital Tract Disease·H K HaefnerS M Selvaggi
Mar 26, 2003·Clinical and Experimental Dermatology·G L Tasker, F Wojnarowska
Aug 23, 2019·Journal of the American Academy of Dermatology·Beth MorrelSuzanne G M A Pasmans
Jan 5, 2005·Pediatrics·Mandi L Maronn, Nancy B Esterly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.